The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

Oxford BioMedica plc (OXB.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)

Add to watchlist

222.50

+7.50

(+3.49%)

As of 03:03PM BST. Market open.

Currency in GBp

Earnings estimate	Current qtr. (Dec 2023)	Next qtr. (Mar 2024)	Current year (2023)	Next year (2024)
No. of analysts	0	0	7	5
Avg. Estimate	0	0	-89.57	-41.43
Low estimate	0	0	-98.79	-53.1
High estimate	0	0	-80.79	-33
Year ago EPS	N/A	N/A	-41.29	-89.57

Revenue estimate	Current qtr. (Dec 2023)	Next qtr. (Mar 2024)	Current year (2023)	Next year (2024)
No. of analysts	0	0	9	8
Avg. Estimate	N/A	N/A	90.33M	127.59M
Low estimate	N/A	N/A	89M	114.6M
High estimate	N/A	N/A	91.4M	136M
Year ago sales	N/A	N/A	139.99M	90.33M
Sales growth (year/est)	N/A	N/A	-35.50%	41.20%

Earnings history	Invalid Date	Invalid Date	Invalid Date	Invalid Date
Est. EPS	N/A	N/A	N/A	N/A
Actual EPS	N/A	N/A	N/A	N/A
Difference	N/A	N/A	N/A	N/A
Surprise %	N/A	N/A	N/A	N/A

EPS trend	Current year (2023)	Next year (2024)
Current estimate	-89.57	-41.43
7 days ago	-90.31	-42.35
30 days ago	-90.31	-42.4
60 days ago	-92.06	-37.74
90 days ago	-92.06	-37.74

EPS revisions	Current qtr. (Dec 2023)	Next qtr. (Mar 2024)	Current year (2023)	Next year (2024)
Up last 7 days	N/A	N/A	1	1
Up last 30 days	N/A	N/A	1	1
Down last 7 days	N/A	N/A	N/A	N/A
Down last 30 days	N/A	N/A	N/A	N/A

Growth estimates	OXB.L	Industry	Sector(s)	S&P 500
Current qtr.	N/A	N/A	N/A	N/A
Next qtr.	N/A	N/A	N/A	N/A
Current year	-116.90%	N/A	N/A	N/A
Next year	53.70%	N/A	N/A	N/A
Next 5 years (per annum)	N/A	N/A	N/A	N/A
Past 5 years (per annum)	N/A	N/A	N/A	N/A